Conversion of spironolactone to an active metabolite in target tissues: formation of 7α-thiospironolactone by microsomal preparations from guinea pig liver, adrenals, kidneys, and testes
Authors:
- James H. SherryJSJames H. Sherry
- John P. O'DonnellJOJohn P. O'Donnell
- Howard D. ColbyHCHoward D. Colby
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 29 (26) , 2727-2736
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Relation of Canrenone to the Actions of Spironolactone on Adrenal Cytochrome P-450-Dependent Enzymes*Endocrinology, 1978
- Spironolactone: Disposition, Metabolism, Pharmacodynamics, and BioavailabilityDrug Metabolism Reviews, 1978
- Spironolactone: Diversity in Metabolic PathwaysXenobiotica, 1977
- Spironolactone and potassium canrenoate in normal manClinical Pharmacology & Therapeutics, 1976
- Spironolactone and cytochrome P-450: Impairment of steroid 21-hydroxylation in the adrenal cortexArchives of Biochemistry and Biophysics, 1976
- Antagonism of fludrocortisone by spironolactone and canrenone [letter].British Journal of Clinical Pharmacology, 1976
- Spironolactone and cytochrome P-450: Impairment of steroid hydroxylation in the adrenal cortexLife Sciences, 1974
- Reduced Aldosterone Secretion During Spironolactone Treatment in Primary Aldosteronism: Report of a CaseThe Journal of Clinical Endocrinology & Metabolism, 1974
- On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitroNaunyn-Schmiedeberg's Archives of Pharmacology, 1973
- BLOCKING THE RENAL ELECTROLYTE EFFECTS OF MINERALOCORTICOIDS WITH AN ORALLY ACTIVE STEROIDAL SPIROLACTONEEndocrinology, 1960